Antibiotics in the second half of the 1980s: Areas of future development and the effect of new agents on aminoglycoside use
- 30 June 1986
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 80 (6) , 195-203
- https://doi.org/10.1016/0002-9343(86)90501-2
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The potential for discovery and development of improved aminoglycosidesThe American Journal of Medicine, 1986
- Antimicrobial activity and beta-lactamase stability of foramidocillinAntimicrobial Agents and Chemotherapy, 1986
- The pharmacokinetic and bactericidal characteristics of oral cefiximeClinical Pharmacology & Therapeutics, 1985
- In-vitro activity and -lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343Journal of Antimicrobial Chemotherapy, 1985
- In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillinAntimicrobial Agents and Chemotherapy, 1984
- Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporinAntimicrobial Agents and Chemotherapy, 1984
- In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporinAntimicrobial Agents and Chemotherapy, 1984
- Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1983
- Antibacterial activity and beta-lactamase stability of temocillinAntimicrobial Agents and Chemotherapy, 1982
- Antibacterial activity of an oral penem, Sch 29482Journal of Antimicrobial Chemotherapy, 1982